Mustang Bio, Inc. announced that its IL13Ra2-targeted CAR T-cell therapy, MB-101, received Orphan Drug Designation from the FDA for treating recurrent diffuse and anaplastic astrocytomas and ...

Community started off the semester with a solid premiere. While “Biology 101” didn’t induce any real belly laughs, the addition of two new guest stars more than made up for it. Hello John Goodman and ...

Remember Biology 101? I sure do. It was the first class I had in my first semester in college at the ripe age of 18. It started at 7:30 in the morning, whether or not I did, and was taught by one of ...

Adaptin Bio has obtained IND clearance from the FDA for APTN-101 in glioblastoma, enabling initiation of a first-in-human phase I trial in patients diagnosed with WHO grade IV malignant glioma.

By: Eunice Jean C. Patron In May 2026, the Institute of Biology (IB) of the University of the Philippines Diliman – College ...